Dr. Ingemar Kihlström has a bachelor's degree in chemistry and biology and is an associate professor of toxicology at Uppsala University. Ingemar has a solid track record as a consultant in pharmaceuticals, biotechnology, medtech and finance. He has previously worked for more than 15 years in R&D and business development at Astra and Pharmacia, as well as almost 10 years in the financial industry as a pharmaceutical analyst and in Corporate Finance for Aros Securities and ABG Sundal Collier. For almost 20 years, Ingemar has mainly been active as a board member in life science and has had several board assignments as chairman and member of mainly listed companies. Independent in relation to the company, company management and major shareholders.